(Reuters) -German packaging and medical equipment maker Gerresheimer cut its guidance for 2025 on Monday, citing continued weak demand in the cosmetics sector and a decline in demand for containment solutions for liquid medications.
It now expects revenues to grow by between 1% and 2% in 2025, down from its previously forecast range of 3-5%, which includes contributions from Bormioli Pharma, it said in a statement.
Gerresheimer, which also makes rounded jars for creams and roll-on bottles for deodorants, also lowered its expected adjusted EBITDA margin to 20%, from 22% previously.
The company also cut its 2024 dividend to 0.04 euros ($0.0457) per share from the 1.25 euros proposed in February in an effort to maintain financial flexibility, it said.
Shares fell as much as 11% after the announcement, and were trading 10.02% down at 1000 GMT, at the bottom of the STOXX 600 index.
($1 = 0.8750 euros)
(Reporting by Isabel Demetz; editing by Matthias Williams and Friederike Heine)
Comments